EXHANCE‐12: 1‐year study of the exhalation delivery system with fluticasone (EDS‐FLU) in chronic rhinosinusitis

BACKGROUND: Inadequate efficacy of current intranasal steroids in chronic rhinosinusitis (CRS) is attributable to ineffective and/or inconsistent drug delivery to target anatomic sites. A new exhalation delivery system with fluticasone (EDS‐FLU) may improve outcomes by significantly increasing super...

Descripción completa

Detalles Bibliográficos
Autores principales: Palmer, James N., Jacobson, Kraig W., Messina, John C., Kosik‐Gonzalez, Colette, Djupesland, Per G., Mahmoud, Ramy A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099484/
https://www.ncbi.nlm.nih.gov/pubmed/29856520
http://dx.doi.org/10.1002/alr.22141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099484/
https://www.ncbi.nlm.nih.gov/pubmed/29856520
http://dx.doi.org/10.1002/alr.22141

Ejemplares similares